ALEMTUZUMAB

ALEMTUZUMAB was reported 19365 times

ALEMTUZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACTINOMYCOTIC SEPSIS 18 0.7200
1 THYROID STIMULATING IMMUNOGLOBULIN 18 0.5806
2 SPECIFIC GRAVITY URINE DECREASED 71 0.4610
3 HAEMOGLOBIN URINE PRESENT 80 0.3941
4 URINE LEUKOCYTE ESTERASE 22 0.3729
5 BACTERIAL TEST 111 0.3725
6 T-CELL PROLYMPHOCYTIC LEUKAEMIA 34 0.3656
7 CRYSTAL URINE PRESENT 187 0.3363
8 SPECIFIC GRAVITY URINE INCREASED 44 0.3284
9 MUCOEPIDERMOID CARCINOMA OF SALIVARY GLAND 19 0.3220
10 URINARY SEDIMENT PRESENT 201 0.3121
11 URINE LEUKOCYTE ESTERASE POSITIVE 218 0.3114
12 BILIRUBIN URINE PRESENT 34 0.2857
13 CELLS IN URINE 22 0.2857
14 UROBILINOGEN URINE INCREASED 46 0.2788
15 NITRITE URINE PRESENT 113 0.2580
16 RED BLOOD CELLS URINE POSITIVE 236 0.2441
17 PYELONEPHRITIS FUNGAL 18 0.2432
18 BAND NEUTROPHIL PERCENTAGE INCREASED 24 0.2308
19 AUTOIMMUNE THYROID DISORDER 23 0.2110
20 PH URINE INCREASED 36 0.2081
21 ADENOVIRUS REACTIVATION 29 0.2014
22 AUTOIMMUNE PANCYTOPENIA 17 0.1868
23 PERINEAL ULCERATION 26 0.1857
24 LYMPHOCYTE PERCENTAGE DECREASED 249 0.1853
25 MICROSPORIDIA INFECTION 64 0.1823
26 MONOCYTE PERCENTAGE INCREASED 118 0.1664
27 NEUTROPHIL PERCENTAGE INCREASED 209 0.1656
28 WHITE BLOOD CELLS URINE POSITIVE 292 0.1551
29 TRI-IODOTHYRONINE FREE INCREASED 26 0.1512
30 HERPES ZOSTER INFECTION NEUROLOGICAL 24 0.1509
31 CD4 LYMPHOCYTES ABNORMAL 31 0.1476
32 IMMUNE THROMBOCYTOPENIC PURPURA 405 0.1432
33 AUTOIMMUNE NEUTROPENIA 40 0.1384
34 GASTROENTERITIS ADENOVIRUS 21 0.1338
35 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 25 0.1316
36 URINARY CASTS 51 0.1311
37 MONOCYTE PERCENTAGE DECREASED 24 0.1304
38 ADENOVIRUS INFECTION 377 0.1299
39 MYELOCYTE COUNT INCREASED 24 0.1277
40 PNEUMONIA ADENOVIRAL 25 0.1263
41 BAND NEUTROPHIL COUNT INCREASED 24 0.1231
42 EOSINOPHIL PERCENTAGE DECREASED 24 0.1206
43 ANTI-THYROID ANTIBODY POSITIVE 55 0.1204
44 LACTOBACILLUS INFECTION 19 0.1159
45 MYCOBACTERIUM KANSASII INFECTION 18 0.1098
46 BRONCHIOLITIS OBLITERANS SYNDROME 19 0.1086
47 ACANTHAMOEBA INFECTION 20 0.1064
48 LEUKOCYTURIA 87 0.1056
49 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 37 0.1016
50 AUTOIMMUNE HYPOTHYROIDISM 24 0.1008
51 URINE KETONE BODY PRESENT 157 0.0994
52 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 129 0.0979
53 BACTERIURIA 55 0.0973
54 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION 20 0.0957
55 THYROXINE FREE INCREASED 61 0.0953
56 GRAFT VERSUS HOST DISEASE IN SKIN 206 0.0934
57 EOSINOPHIL PERCENTAGE INCREASED 50 0.0924
58 LISTERIA SEPSIS 24 0.0909
59 URINE ABNORMALITY 402 0.0883
60 CULTURE URINE POSITIVE 123 0.0875
61 IDIOPATHIC PNEUMONIA SYNDROME 26 0.0872
62 BACTERIAL TEST POSITIVE 194 0.0869
63 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 234 0.0846
64 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 29 0.0826
65 URINE ANALYSIS ABNORMAL 246 0.0822
66 BONE MARROW TRANSPLANT REJECTION 18 0.0818
67 GRAFT LOSS 59 0.0814
68 EPSTEIN-BARR VIRAEMIA 90 0.0812
69 ENDOCRINE OPHTHALMOPATHY 70 0.0806
70 WHITE BLOOD CELLS URINE 22 0.0791
71 TRI-IODOTHYRONINE FREE DECREASED 20 0.0784
72 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 71 0.0767
73 MENINGITIS LISTERIA 38 0.0745
74 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 151 0.0709
75 IMMATURE GRANULOCYTE COUNT INCREASED 20 0.0707
76 CD4 LYMPHOCYTES DECREASED 150 0.0700
77 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 98 0.0694
78 IMMUNE THROMBOCYTOPENIA 314 0.0685
79 VIRAEMIA 93 0.0671
80 GROWTH FAILURE 23 0.0669
81 TRANSPLANT FAILURE 164 0.0668
82 VIRAL HAEMORRHAGIC CYSTITIS 47 0.0660
83 MONOCYTE COUNT DECREASED 80 0.0655
84 CYSTITIS VIRAL 25 0.0653
85 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 36 0.0646
86 CYTOMEGALOVIRUS INFECTION REACTIVATION 284 0.0642
87 ANAEMIA HAEMOLYTIC AUTOIMMUNE 52 0.0628
88 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 45 0.0626
89 HUMAN POLYOMAVIRUS INFECTION 33 0.0621
90 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 311 0.0610
91 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 36 0.0609
92 ACUTE DISSEMINATED ENCEPHALOMYELITIS 21 0.0605
93 THYROXINE FREE DECREASED 34 0.0602
94 JC VIRUS INFECTION 95 0.0594
95 CRYSTALLURIA 32 0.0588
96 LISTERIOSIS 65 0.0588
97 HUMAN HERPESVIRUS 6 INFECTION 111 0.0587
98 LYMPHOCYTE COUNT ABNORMAL 66 0.0586
99 BAND SENSATION 73 0.0575
100 PULMONARY NOCARDIOSIS 46 0.0558
101 BK VIRUS INFECTION 185 0.0548
102 DRUG MONITORING PROCEDURE NOT PERFORMED 97 0.0539
103 T-LYMPHOCYTE COUNT DECREASED 36 0.0528
104 HERPES ZOSTER MENINGOENCEPHALITIS 19 0.0528
105 AUTOIMMUNE HAEMOLYTIC ANAEMIA 181 0.0528
106 VARICELLA ZOSTER VIRUS INFECTION 109 0.0525
107 MENINGITIS TUBERCULOUS 29 0.0519
108 CITROBACTER INFECTION 22 0.0513
109 POLYOMAVIRUS VIRAEMIA 54 0.0508
110 CYTOMEGALOVIRUS INFECTION 839 0.0504
111 LYMPHOCYTE COUNT DECREASED 879 0.0497
112 MEAN CELL HAEMOGLOBIN DECREASED 91 0.0497
113 AUTOIMMUNE THYROIDITIS 185 0.0489
114 RED CELL DISTRIBUTION WIDTH INCREASED 202 0.0486
115 CYTOMEGALOVIRUS VIRAEMIA 207 0.0465
116 GRAFT VERSUS HOST DISEASE IN LUNG 22 0.0460
117 PNEUMONIA CYTOMEGALOVIRAL 89 0.0458
118 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 79 0.0447
119 BLOOD THYROID STIMULATING HORMONE DECREASED 201 0.0442
120 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 73 0.0437
121 EPSTEIN-BARR VIRUS INFECTION 272 0.0435
122 MEAN CELL VOLUME DECREASED 65 0.0421
123 VENOOCCLUSIVE DISEASE 105 0.0419
124 NEUTROPHIL PERCENTAGE DECREASED 22 0.0413
125 GRAFT VERSUS HOST DISEASE 296 0.0411
126 MEAN PLATELET VOLUME DECREASED 34 0.0405
127 CELLULITIS STAPHYLOCOCCAL 26 0.0399
128 GRAFT VERSUS HOST DISEASE IN LIVER 27 0.0377
129 FUSARIUM INFECTION 26 0.0371
130 TOXOPLASMOSIS 40 0.0370
131 CHRONIC GRAFT VERSUS HOST DISEASE 132 0.0365
132 DRUG EXPOSURE BEFORE PREGNANCY 37 0.0365
133 LYMPHOPENIA 509 0.0360
134 ACUTE GRAFT VERSUS HOST DISEASE 161 0.0351
135 LEGIONELLA INFECTION 20 0.0350
136 FOCAL NODULAR HYPERPLASIA 18 0.0346
137 GASTROENTERITIS NOROVIRUS 46 0.0346
138 EVANS SYNDROME 17 0.0345
139 PNEUMONIA NECROTISING 22 0.0340
140 ENTEROCOCCAL BACTERAEMIA 36 0.0340
141 DELAYED GRAFT FUNCTION 24 0.0338
142 ENCEPHALITIS VIRAL 41 0.0337
143 HERPES SIMPLEX 216 0.0332
144 MEAN PLATELET VOLUME INCREASED 20 0.0331
145 SYSTEMIC MYCOSIS 37 0.0317
146 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 22 0.0316
147 THYROID HORMONES INCREASED 33 0.0314
148 MEAN CELL HAEMOGLOBIN INCREASED 52 0.0314
149 ROTAVIRUS INFECTION 18 0.0312
150 PARAINFLUENZAE VIRUS INFECTION 46 0.0302
151 TRANSPLANT REJECTION 236 0.0294
152 MAGNETIC RESONANCE IMAGING ABNORMAL 35 0.0293
153 PROTEIN URINE PRESENT 144 0.0289
154 INFECTION REACTIVATION 33 0.0288
155 LEUKAEMIA RECURRENT 48 0.0284
156 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 94 0.0283
157 URINARY TRACT INFECTION BACTERIAL 67 0.0265
158 MONOCYTE COUNT INCREASED 95 0.0261
159 NOCARDIOSIS 66 0.0258
160 RED BLOOD CELL COUNT INCREASED 71 0.0257
161 B-LYMPHOCYTE COUNT DECREASED 35 0.0257
162 ACQUIRED HAEMOPHILIA 25 0.0250
163 BLOOD CREATININE DECREASED 78 0.0249
164 RETICULOCYTE COUNT INCREASED 20 0.0247
165 APLASTIC ANAEMIA 129 0.0247
166 NORMOCYTIC ANAEMIA 36 0.0245
167 RELAPSING-REMITTING MULTIPLE SCLEROSIS 21 0.0243
168 BLADDER CATHETERISATION 23 0.0237
169 HERPES ZOSTER DISSEMINATED 19 0.0237
170 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 193 0.0234
171 BLOOD THYROID STIMULATING HORMONE ABNORMAL 43 0.0233
172 CENTRAL NERVOUS SYSTEM LYMPHOMA 32 0.0232
173 THYROID FUNCTION TEST ABNORMAL 94 0.0226
174 CYTOMEGALOVIRUS TEST POSITIVE 40 0.0224
175 BACTERIAL SEPSIS 73 0.0224
176 HAEMATOCRIT INCREASED 51 0.0224
177 FUNGAEMIA 35 0.0222
178 MENINGITIS VIRAL 30 0.0219
179 GLUCOSE URINE PRESENT 27 0.0212
180 PNEUMONIA LEGIONELLA 34 0.0212
181 BLOOD THYROID STIMULATING HORMONE INCREASED 194 0.0211
182 POLYMYOSITIS 37 0.0209
183 STENOTROPHOMONAS INFECTION 28 0.0206
184 ANOGENITAL WARTS 18 0.0202
185 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 25 0.0200
186 ASPERGILLOSIS 26 0.0199
187 ACUTE MYELOID LEUKAEMIA RECURRENT 42 0.0195
188 EXOPHTHALMOS 42 0.0195
189 MEAN CELL VOLUME INCREASED 50 0.0195
190 HYPERTHYROIDISM 280 0.0193
191 VENOOCCLUSIVE LIVER DISEASE 95 0.0192
192 MICROANGIOPATHY 18 0.0191
193 OBLITERATIVE BRONCHIOLITIS 25 0.0190
194 PSEUDOMONAL SEPSIS 33 0.0188
195 BLOOD URINE PRESENT 356 0.0187
196 T-CELL LYMPHOMA 21 0.0183
197 VITILIGO 43 0.0183
198 RENAL TRANSPLANT FAILURE 18 0.0182
199 POST HERPETIC NEURALGIA 26 0.0181
200 CYTOMEGALOVIRUS CHORIORETINITIS 35 0.0179
201 THROMBOTIC MICROANGIOPATHY 173 0.0177
202 NEUTROPHIL COUNT INCREASED 180 0.0176
203 LYMPHOPROLIFERATIVE DISORDER 51 0.0173
204 THYROIDITIS 52 0.0173
205 PAROTITIS 20 0.0172
206 BRONCHOPULMONARY ASPERGILLOSIS 133 0.0171
207 CYSTITIS HAEMORRHAGIC 69 0.0171
208 AUTOIMMUNE DISORDER 166 0.0170
209 KLEBSIELLA SEPSIS 19 0.0169
210 THROMBOTIC THROMBOCYTOPENIC PURPURA 59 0.0167
211 OPHTHALMOPLEGIA 26 0.0165
212 QUADRIPARESIS 27 0.0163
213 HEPATOSPLENOMEGALY 41 0.0160
214 ESCHERICHIA TEST POSITIVE 19 0.0159
215 MYCOBACTERIAL INFECTION 27 0.0157
216 HAEMATOCRIT DECREASED 309 0.0156
217 PROCALCITONIN INCREASED 18 0.0153
218 STEM CELL TRANSPLANT 38 0.0152
219 PARAPARESIS 27 0.0151
220 OPPORTUNISTIC INFECTION 28 0.0151
221 ENTEROCOCCAL INFECTION 73 0.0151
222 HAEMOLYTIC ANAEMIA 131 0.0146
223 TRANSPLANT DYSFUNCTION 26 0.0146
224 IDIOPATHIC THROMBOCYTOPENIC PURPURA 23 0.0145
225 PAPILLARY THYROID CANCER 25 0.0144
226 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 106 0.0141
227 PETECHIAE 147 0.0141
228 ASPERGILLUS INFECTION 91 0.0139
229 VARICELLA 33 0.0138
230 KIDNEY TRANSPLANT REJECTION 66 0.0137
231 CHRONIC LYMPHOCYTIC LEUKAEMIA 64 0.0135
232 MULTIPLE SCLEROSIS RELAPSE 923 0.0135
233 PSEUDOMONAS INFECTION 114 0.0133
234 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 31 0.0132
235 MUCOSAL INFLAMMATION 345 0.0132
236 STAPHYLOCOCCAL BACTERAEMIA 57 0.0131
237 EOSINOPHIL COUNT INCREASED 109 0.0131
238 PAPILLOMA VIRAL INFECTION 21 0.0127
239 EOSINOPHIL COUNT DECREASED 30 0.0126
240 MENINGITIS CRYPTOCOCCAL 22 0.0126
241 PLATELET COUNT ABNORMAL 75 0.0124
242 B-CELL LYMPHOMA 42 0.0124
243 DIFFUSE LARGE B-CELL LYMPHOMA 95 0.0123
244 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 61 0.0122
245 COMPLICATIONS OF TRANSPLANTED KIDNEY 27 0.0119
246 NEUROGENIC BLADDER 25 0.0118
247 PULMONARY HAEMORRHAGE 92 0.0117
248 BODY TEMPERATURE INCREASED 239 0.0117
249 WHITE BLOOD CELL COUNT ABNORMAL 74 0.0116
250 FIBRIN D DIMER INCREASED 41 0.0115
251 THYROIDECTOMY 20 0.0115
252 GOITRE 47 0.0115
253 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 109 0.0114
254 PULMONARY ALVEOLAR HAEMORRHAGE 64 0.0114
255 HISTOPLASMOSIS DISSEMINATED 18 0.0113
256 LUNG CONSOLIDATION 31 0.0111
257 KLEBSIELLA INFECTION 56 0.0111
258 BRAIN ABSCESS 28 0.0111
259 APLASIA PURE RED CELL 38 0.0110
260 THYROID DISORDER 170 0.0110
261 FUNGAL SKIN INFECTION 44 0.0109
262 GROWTH RETARDATION 32 0.0109
263 HYPOGAMMAGLOBULINAEMIA 71 0.0108
264 HISTIOCYTOSIS HAEMATOPHAGIC 32 0.0108
265 PNEUMOCYSTIS JIROVECI PNEUMONIA 24 0.0108
266 GUILLAIN-BARRE SYNDROME 52 0.0107
267 CERVICAL DYSPLASIA 23 0.0105
268 PNEUMONIA FUNGAL 41 0.0104
269 LYMPHOCYTOSIS 22 0.0102
270 INFUSION SITE BRUISING 22 0.0102
271 HERPES VIRUS INFECTION 58 0.0101
272 WALKING DISABILITY 21 0.0100
273 ENCEPHALITIS 69 0.0100
274 SYSTEMIC CANDIDA 25 0.0099
275 CYTOMEGALOVIRUS COLITIS 22 0.0096
276 OESOPHAGEAL CANDIDIASIS 38 0.0095
277 PARESIS 21 0.0094
278 OPTIC NEURITIS 85 0.0093
279 BLOOD CULTURE POSITIVE 28 0.0093
280 WHITE BLOOD CELL DISORDER 25 0.0093
281 INFUSION SITE EXTRAVASATION 58 0.0093
282 ESCHERICHIA SEPSIS 27 0.0093
283 VULVOVAGINAL MYCOTIC INFECTION 36 0.0091
284 ESCHERICHIA URINARY TRACT INFECTION 38 0.0089
285 ACTINIC KERATOSIS 23 0.0089
286 NEUTROPHIL COUNT ABNORMAL 25 0.0088
287 HAEMOGLOBIN INCREASED 40 0.0088
288 STAPHYLOCOCCAL SEPSIS 43 0.0087
289 MUSCLE SPASTICITY 107 0.0087
290 POOR VENOUS ACCESS 90 0.0087
291 DYSGRAPHIA 57 0.0086
292 PERONEAL NERVE PALSY 49 0.0086
293 CENTRAL NERVOUS SYSTEM LESION 118 0.0086
294 RENAL TUBULAR DISORDER 24 0.0085
295 SKIN PAPILLOMA 34 0.0085
296 MULTIPLE ORGAN DYSFUNCTION SYNDROME 240 0.0085
297 MUCORMYCOSIS 22 0.0085
298 TRIGEMINAL NEURALGIA 34 0.0084
299 MULTI-ORGAN FAILURE 146 0.0084
300 LEUKOPENIA 422 0.0084
301 TEMPERATURE INTOLERANCE 87 0.0084
302 COMPUTERISED TOMOGRAM ABNORMAL 19 0.0084
303 HERPES ZOSTER 482 0.0084
304 PNEUMOCYSTIS JIROVECII PNEUMONIA 82 0.0082
305 URINE ODOUR ABNORMAL 48 0.0082
306 HYPOTHYROIDISM 259 0.0081
307 HEMIPARESIS 137 0.0081
308 INFUSION SITE PAIN 104 0.0081
309 BRADYCARDIA 425 0.0080
310 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 30 0.0078
311 RED BLOOD CELL COUNT DECREASED 223 0.0078
312 IMMUNODEFICIENCY 116 0.0078
313 NEUROLOGICAL DECOMPENSATION 18 0.0078
314 WHEELCHAIR USER 34 0.0076
315 LUNG OPACITY 20 0.0076
316 DISSEMINATED TUBERCULOSIS 19 0.0074
317 IMMUNOSUPPRESSION 65 0.0074
318 END STAGE RENAL DISEASE 133 0.0073
319 PIGMENTATION DISORDER 45 0.0073
320 GRIP STRENGTH DECREASED 64 0.0073
321 CLOSTRIDIUM DIFFICILE COLITIS 77 0.0073
322 MYOSITIS 65 0.0072
323 SINUS BRADYCARDIA 70 0.0072
324 PATHOGEN RESISTANCE 66 0.0072
325 PROTEIN TOTAL DECREASED 27 0.0072
326 CUSHINGOID 23 0.0072
327 EAR PRURITUS 25 0.0071
328 MELANOCYTIC NAEVUS 31 0.0071
329 INCREASED TENDENCY TO BRUISE 65 0.0071
330 BACTERAEMIA 83 0.0070
331 GINGIVAL BLEEDING 95 0.0070
332 PARAPLEGIA 20 0.0069
333 PLEURITIC PAIN 19 0.0069
334 ODYNOPHAGIA 41 0.0069
335 WALKING AID USER 45 0.0068
336 SERUM FERRITIN INCREASED 36 0.0068
337 PANCYTOPENIA 381 0.0068
338 CANDIDA INFECTION 115 0.0068
339 MULTIPLE SCLEROSIS 325 0.0068
340 PNEUMONITIS 183 0.0067
341 PLATELET COUNT DECREASED 710 0.0067
342 ORGANISING PNEUMONIA 33 0.0067
343 POOR QUALITY SLEEP 141 0.0065
344 RENAL CELL CARCINOMA 32 0.0065
345 SENSORY LOSS 52 0.0065
346 MENSTRUAL DISORDER 53 0.0064
347 VASCULAR DEVICE INFECTION 29 0.0064
348 AUTOIMMUNE HEPATITIS 44 0.0063
349 HEPATITIS B 38 0.0063
350 ACUTE RESPIRATORY DISTRESS SYNDROME 111 0.0063
351 FINE MOTOR SKILL DYSFUNCTION 18 0.0062
352 NYSTAGMUS 33 0.0062
353 MICTURITION URGENCY 70 0.0061
354 WHITE BLOOD CELL COUNT DECREASED 658 0.0061
355 INFUSION SITE PRURITUS 19 0.0060
356 ATYPICAL PNEUMONIA 18 0.0060
357 STAPHYLOCOCCAL INFECTION 198 0.0060
358 MATERNAL EXPOSURE BEFORE PREGNANCY 41 0.0060
359 IMMUNE SYSTEM DISORDER 79 0.0060
360 PLATELET COUNT INCREASED 78 0.0060
361 PNEUMONIA VIRAL 19 0.0060
362 BONE MARROW DISORDER 18 0.0060
363 REHABILITATION THERAPY 23 0.0059
364 LUNG INFILTRATION 52 0.0059
365 LYMPHOCYTE COUNT INCREASED 19 0.0058
366 TUMOUR LYSIS SYNDROME 51 0.0058
367 LABORATORY TEST ABNORMAL 171 0.0058
368 ESCHERICHIA INFECTION 47 0.0057
369 SARCOIDOSIS 27 0.0057
370 LIMB DISCOMFORT 175 0.0056
371 NEUTROPHIL COUNT DECREASED 230 0.0056
372 CARDIOPULMONARY FAILURE 22 0.0056
373 CYTOPENIA 69 0.0056
374 ATAXIA 66 0.0056
375 MENINGITIS 37 0.0055
376 THROMBOCYTOPENIA 613 0.0055
377 CHEST DISCOMFORT 554 0.0054
378 RHINOVIRUS INFECTION 21 0.0054
379 MUSCULAR WEAKNESS 611 0.0054
380 LEUKOENCEPHALOPATHY 20 0.0054
381 CHOLECYSTITIS ACUTE 30 0.0053
382 SPLENOMEGALY 62 0.0053
383 ORAL HERPES 103 0.0053
384 HEART RATE DECREASED 185 0.0053
385 FEELING COLD 146 0.0052
386 PARONYCHIA 23 0.0052
387 URINARY INCONTINENCE 155 0.0052
388 THYROID MASS 20 0.0052
389 BLOOD CREATININE ABNORMAL 18 0.0052
390 UROSEPSIS 48 0.0052
391 MUSCULOSKELETAL DISORDER 99 0.0052
392 FEBRILE BONE MARROW APLASIA 22 0.0052
393 RALES 30 0.0052
394 ENTERITIS 33 0.0052
395 PYREXIA 1784 0.0052
396 PROTEINURIA 98 0.0051
397 HYDROCEPHALUS 28 0.0051
398 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 26 0.0051
399 TACHYCARDIA 456 0.0051
400 DEMYELINATION 21 0.0051
401 FUNGAL INFECTION 170 0.0051
402 HAEMORRHAGIC DIATHESIS 18 0.0051
403 DYSSTASIA 147 0.0050
404 FEBRILE NEUTROPENIA 333 0.0050
405 C-REACTIVE PROTEIN INCREASED 182 0.0050
406 LYMPHADENOPATHY 175 0.0049
407 INFUSION SITE SWELLING 31 0.0049
408 HAEMOLYSIS 38 0.0049
409 URINARY TRACT INFECTION 835 0.0049
410 DIARRHOEA HAEMORRHAGIC 45 0.0048
411 CYSTITIS 153 0.0048
412 VEIN DISORDER 24 0.0048
413 NEUTROPENIA 649 0.0048
414 WHITE BLOOD CELL COUNT INCREASED 182 0.0047
415 MENORRHAGIA 93 0.0047
416 DRUG RESISTANCE 121 0.0047
417 MALIGNANT MELANOMA 63 0.0047
418 FEELING HOT 286 0.0047
419 HAEMOPTYSIS 130 0.0047
420 DIPLOPIA 121 0.0047
421 GLOMERULAR FILTRATION RATE DECREASED 57 0.0046
422 MOUTH HAEMORRHAGE 34 0.0046
423 VIRAL UPPER RESPIRATORY TRACT INFECTION 22 0.0046
424 DECREASED IMMUNE RESPONSIVENESS 45 0.0046
425 FRUSTRATION TOLERANCE DECREASED 37 0.0046
426 FACIAL PARALYSIS 39 0.0046
427 DYSURIA 167 0.0045
428 SEPSIS 506 0.0045
429 BLADDER DISORDER 45 0.0045
430 CHROMATURIA 102 0.0045
431 CONTUSION 432 0.0045
432 FLUSHING 454 0.0045
433 ABSCESS LIMB 19 0.0045
434 GASTROENTERITIS 65 0.0044
435 CHOLECYSTITIS 53 0.0044
436 RESPIRATORY FAILURE 320 0.0044
437 ACUTE MYELOID LEUKAEMIA 68 0.0044
438 SQUAMOUS CELL CARCINOMA 41 0.0044
439 MOTOR DYSFUNCTION 44 0.0043
440 SEPTIC SHOCK 187 0.0043
441 BEDRIDDEN 56 0.0043
442 CHILLS 499 0.0043
443 HAEMOGLOBIN DECREASED 437 0.0043
444 VAGINAL INFECTION 20 0.0042
445 PERICARDIAL EFFUSION 98 0.0042
446 BACTERIAL INFECTION 79 0.0042
447 HAEMATURIA 145 0.0042
448 INCORRECT DRUG ADMINISTRATION RATE 18 0.0042
449 PERIPHERAL COLDNESS 58 0.0042
450 LUNG NEOPLASM 18 0.0042
451 HEPATIC ENZYME ABNORMAL 21 0.0042
452 BLOOD LACTATE DEHYDROGENASE INCREASED 65 0.0041
453 ORAL CANDIDIASIS 54 0.0041
454 GASTROENTERITIS VIRAL 74 0.0041
455 MYELODYSPLASTIC SYNDROME 59 0.0041
456 NEUTROPENIC SEPSIS 29 0.0041
457 DECUBITUS ULCER 33 0.0040
458 IMPAIRED DRIVING ABILITY 46 0.0040
459 BLOOD ALBUMIN DECREASED 32 0.0040
460 HYDRONEPHROSIS 30 0.0040
461 ANAL INCONTINENCE 36 0.0040
462 BLOOD BILIRUBIN INCREASED 108 0.0040
463 BASAL CELL CARCINOMA 62 0.0040
464 SENSORY DISTURBANCE 63 0.0039
465 FEELING OF BODY TEMPERATURE CHANGE 23 0.0039
466 CEREBRAL DISORDER 29 0.0039
467 HYPERAESTHESIA 32 0.0039
468 BONE MARROW FAILURE 79 0.0039
469 BLOOD UREA INCREASED 65 0.0039
470 HEMIPLEGIA 32 0.0038
471 APHASIA 116 0.0038
472 OROPHARYNGEAL PAIN 355 0.0038
473 TACHYPNOEA 52 0.0038
474 ASCITES 112 0.0038
475 PYELONEPHRITIS 33 0.0038
476 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 23 0.0038
477 URINE OUTPUT DECREASED 33 0.0038
478 BLOOD TEST ABNORMAL 53 0.0038
479 NEPHROPATHY 35 0.0037
480 HAEMOGLOBIN ABNORMAL 24 0.0037
481 ALANINE AMINOTRANSFERASE INCREASED 228 0.0037
482 CARDIAC FLUTTER 24 0.0037
483 PHLEBITIS 19 0.0037
484 GAMMA-GLUTAMYLTRANSFERASE INCREASED 82 0.0037
485 HYPOAESTHESIA 553 0.0037
486 INFUSION SITE ERYTHEMA 31 0.0037
487 LUNG INFECTION 57 0.0037
488 NEPHROPATHY TOXIC 41 0.0036
489 NEURALGIA 88 0.0036
490 VASCULITIS 42 0.0036
491 POLYARTHRITIS 19 0.0036
492 DEVICE RELATED INFECTION 55 0.0036
493 HAEMODIALYSIS 30 0.0036
494 ACUTE PULMONARY OEDEMA 20 0.0036
495 SARS-COV-2 TEST POSITIVE 47 0.0036
496 VAGINAL DISCHARGE 36 0.0036
497 PLEURISY 21 0.0035
498 HEART RATE INCREASED 349 0.0035
499 RESPIRATORY DISTRESS 97 0.0035
500 RASH GENERALISED 91 0.0035
501 HAEMATOMA 91 0.0035
502 PURPURA 31 0.0035
503 EAR PAIN 68 0.0035
504 POLLAKIURIA 144 0.0034
505 MOBILITY DECREASED 248 0.0034
506 TONSILLITIS 18 0.0034
507 VIRAL INFECTION 114 0.0034
508 GAIT DISTURBANCE 655 0.0034
509 HICCUPS 28 0.0034
510 RESPIRATORY DISORDER 102 0.0034
511 RENAL TUBULAR NECROSIS 33 0.0034
512 BALANCE DISORDER 290 0.0034
513 ECCHYMOSIS 23 0.0034
514 PROTHROMBIN TIME PROLONGED 20 0.0033
515 RED BLOOD CELL SEDIMENTATION RATE INCREASED 37 0.0033
516 COGNITIVE DISORDER 156 0.0033
517 RASH PRURITIC 181 0.0033
518 ACUTE RESPIRATORY FAILURE 64 0.0033
519 NEUROLOGICAL SYMPTOM 19 0.0033
520 BLOOD CREATININE INCREASED 215 0.0033
521 HYPERTHERMIA 25 0.0033
522 CHOKING SENSATION 18 0.0033
523 GAIT INABILITY 109 0.0033
524 HYPOVOLAEMIA 19 0.0032
525 URTICARIA 541 0.0032
526 HEART RATE ABNORMAL 18 0.0032
527 DYSARTHRIA 121 0.0032
528 MUSCLE TIGHTNESS 52 0.0032
529 ATELECTASIS 31 0.0032
530 SINUS CONGESTION 43 0.0032
531 RASH ERYTHEMATOUS 152 0.0032
532 PNEUMONIA BACTERIAL 29 0.0032
533 HEPATOMEGALY 31 0.0032
534 DRY THROAT 32 0.0031
535 URINARY RETENTION 105 0.0031
536 ACIDOSIS 24 0.0031
537 HYPERSOMNIA 90 0.0031
538 ANURIA 27 0.0031
539 INCONTINENCE 33 0.0031
540 BLOOD CALCIUM DECREASED 35 0.0031
541 THROAT IRRITATION 138 0.0031
542 HEPATIC FAILURE 92 0.0030
543 SOMNAMBULISM 20 0.0030
544 CYTOKINE RELEASE SYNDROME 61 0.0030
545 HEADACHE 1906 0.0030
546 SINUS TACHYCARDIA 43 0.0030
547 COAGULOPATHY 50 0.0030
548 PLEURAL EFFUSION 182 0.0030
549 RESPIRATORY SYNCYTIAL VIRUS INFECTION 26 0.0030
550 PHARYNGITIS 37 0.0030
551 MALNUTRITION 33 0.0029
552 NIGHT SWEATS 94 0.0029
553 FACIAL PAIN 26 0.0029
554 PHOTOSENSITIVITY REACTION 48 0.0029
555 JOINT EFFUSION 20 0.0029
556 BLOOD ALKALINE PHOSPHATASE INCREASED 72 0.0029
557 NECK PAIN 162 0.0029
558 RESPIRATORY TRACT CONGESTION 46 0.0029
559 HEART RATE IRREGULAR 65 0.0029
560 COORDINATION ABNORMAL 40 0.0029
561 EOSINOPHILIA 50 0.0029
562 DISSEMINATED INTRAVASCULAR COAGULATION 40 0.0028
563 BRONCHIECTASIS 19 0.0028
564 SKIN LESION 77 0.0028
565 UNEVALUABLE EVENT 212 0.0028
566 HYPERBILIRUBINAEMIA 29 0.0028
567 OSTEOPENIA 42 0.0028
568 RASH PAPULAR 62 0.0028
569 INFECTION 400 0.0028
570 PHARYNGEAL SWELLING 27 0.0028
571 RASH 1200 0.0028
572 PULMONARY MASS 41 0.0027
573 INFLUENZA 306 0.0027
574 ORAL DISORDER 20 0.0027
575 APHONIA 38 0.0027
576 CONCUSSION 21 0.0027
577 LEUKOCYTOSIS 49 0.0027
578 LOWER RESPIRATORY TRACT INFECTION 123 0.0027
579 INFUSION RELATED REACTION 179 0.0027
580 TRANSAMINASES INCREASED 60 0.0027
581 DISABILITY 53 0.0027
582 JAUNDICE 72 0.0027
583 INTESTINAL PERFORATION 30 0.0027
584 VITAMIN D DEFICIENCY 26 0.0027
585 CLOSTRIDIUM DIFFICILE INFECTION 58 0.0027
586 MASS 37 0.0026
587 SKIN REACTION 37 0.0026
588 NEUROTOXICITY 46 0.0026
589 BRAIN OEDEMA 33 0.0026
590 VERTIGO 159 0.0026
591 UPPER RESPIRATORY TRACT INFECTION 120 0.0026
592 HEPATITIS 66 0.0026
593 PRODUCTIVE COUGH 123 0.0026
594 THYROID CANCER 31 0.0026
595 CORONAVIRUS INFECTION 17 0.0026
596 ENCEPHALOPATHY 63 0.0026
597 HEAVY MENSTRUAL BLEEDING 23 0.0026
598 RENAL PAIN 27 0.0025
599 GINGIVAL PAIN 20 0.0025
600 HYPERLIPIDAEMIA 30 0.0025
601 ASTHENIA 942 0.0025
602 PULMONARY CONGESTION 33 0.0025
603 HYPOXIA 88 0.0025
604 KIDNEY INFECTION 49 0.0025
605 PREGNANCY 50 0.0025
606 WHEEZING 148 0.0025
607 PHARYNGITIS STREPTOCOCCAL 27 0.0025
608 SENSATION OF FOREIGN BODY 21 0.0025
609 MOVEMENT DISORDER 80 0.0025
610 SKIN PLAQUE 21 0.0025
611 RASH MACULAR 87 0.0025
612 ACUTE HEPATIC FAILURE 34 0.0025
613 MENTAL STATUS CHANGES 69 0.0025
614 TRANSFUSION 26 0.0025
615 RESPIRATORY RATE INCREASED 22 0.0025
616 SPINAL PAIN 29 0.0025
617 DIZZINESS POSTURAL 24 0.0025
618 DERMATITIS ALLERGIC 31 0.0025
619 DYSPHONIA 144 0.0025
620 PNEUMOTHORAX 39 0.0025
621 SKIN DISCOLOURATION 113 0.0025
622 FLANK PAIN 23 0.0025
623 APHTHOUS ULCER 19 0.0024
624 ABSCESS 39 0.0024
625 COUGH 682 0.0024
626 PARAESTHESIA 381 0.0024
627 ILL-DEFINED DISORDER 147 0.0024
628 HYPOKINESIA 35 0.0024
629 INCREASED APPETITE 46 0.0024
630 FATIGUE 1874 0.0024
631 EPISTAXIS 180 0.0024
632 SPEECH DISORDER 126 0.0024
633 ASPARTATE AMINOTRANSFERASE INCREASED 127 0.0024
634 MEMORY IMPAIRMENT 328 0.0024
635 CONDITION AGGRAVATED 725 0.0024
636 PRODUCT USE IN UNAPPROVED INDICATION 588 0.0024
637 FEEDING DISORDER 48 0.0024
638 RHINITIS 19 0.0024
639 LIPASE INCREASED 18 0.0023
640 LEUKAEMIA 22 0.0023
641 ELECTROLYTE IMBALANCE 27 0.0023
642 TREMOR 385 0.0023
643 MYOPATHY 20 0.0023
644 MENSTRUATION IRREGULAR 62 0.0023
645 HYPERTENSION 478 0.0023
646 THROAT TIGHTNESS 61 0.0023
647 RASH MACULO-PAPULAR 50 0.0022
648 PALLOR 61 0.0022
649 SKIN INFECTION 25 0.0022
650 RESPIRATORY TRACT INFECTION 58 0.0022
651 DECREASED ACTIVITY 24 0.0022
652 INSOMNIA 592 0.0022
653 STATUS EPILEPTICUS 25 0.0022
654 ERYTHEMA 454 0.0022
655 PALPITATIONS 258 0.0022
656 MUSCLE STRAIN 19 0.0022
657 BRAIN INJURY 22 0.0022
658 SINUS DISORDER 43 0.0022
659 PERSONALITY CHANGE 20 0.0022
660 FEELING ABNORMAL 515 0.0021
661 APPENDICITIS 20 0.0021
662 HAEMORRHAGE INTRACRANIAL 32 0.0021
663 BLOOD PRESSURE INCREASED 323 0.0021
664 BLOOD COUNT ABNORMAL 32 0.0021
665 PARALYSIS 30 0.0021
666 SNEEZING 47 0.0021
667 MYOCARDITIS 24 0.0021
668 RESTLESS LEGS SYNDROME 38 0.0021
669 SUPRAVENTRICULAR TACHYCARDIA 20 0.0021
670 RHINORRHOEA 135 0.0021
671 CHEST PAIN 383 0.0021
672 MUSCULOSKELETAL CHEST PAIN 32 0.0021
673 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 113 0.0021
674 OCULAR DISCOMFORT 23 0.0020
675 PAIN IN JAW 58 0.0020
676 COLD SWEAT 36 0.0020
677 BLOOD POTASSIUM DECREASED 61 0.0020
678 BACK PAIN 471 0.0020
679 PERICARDITIS 34 0.0020
680 RENAL FAILURE 268 0.0020
681 CEREBRAL HAEMORRHAGE 72 0.0020
682 PNEUMONIA 650 0.0020
683 HYPOTENSION 402 0.0020
684 HYPERHIDROSIS 258 0.0020
685 NASOPHARYNGITIS 368 0.0020
686 INFLAMMATION 103 0.0020
687 HYPOAESTHESIA ORAL 30 0.0020
688 GENERAL PHYSICAL HEALTH DETERIORATION 227 0.0020
689 BLOOD PRESSURE DECREASED 130 0.0020
690 RENAL IMPAIRMENT 164 0.0020
691 IRON DEFICIENCY ANAEMIA 18 0.0019
692 INITIAL INSOMNIA 20 0.0019
693 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 20 0.0019
694 PRURITUS GENERALISED 42 0.0019
695 LYMPHOMA 30 0.0019
696 OFF LABEL USE 1698 0.0019
697 BLOOD IRON DECREASED 23 0.0019
698 EPILEPSY 59 0.0019
699 EAR INFECTION 51 0.0019
700 GASTRITIS 50 0.0019
701 DYSPHAGIA 180 0.0019
702 MIGRAINE 181 0.0019
703 SINUSITIS 194 0.0019
704 ANAEMIA 359 0.0019
705 CIRCULATORY COLLAPSE 32 0.0019
706 EYELID PTOSIS 19 0.0019
707 ABDOMINAL PAIN 433 0.0019
708 DYSPEPSIA 183 0.0019
709 LIVER FUNCTION TEST ABNORMAL 54 0.0019
710 THERAPEUTIC RESPONSE DECREASED 112 0.0018
711 HEPATOCELLULAR INJURY 26 0.0018
712 ORAL PAIN 41 0.0018
713 JOINT INJURY 39 0.0018
714 OSTEOMYELITIS 33 0.0018
715 UNRESPONSIVE TO STIMULI 47 0.0018
716 LIGAMENT SPRAIN 18 0.0018
717 SUBDURAL HAEMATOMA 26 0.0018
718 CRYING 66 0.0018
719 ADRENAL INSUFFICIENCY 22 0.0018
720 DISEASE RECURRENCE 85 0.0018
721 EMOTIONAL DISORDER 55 0.0018
722 DISEASE PROGRESSION 211 0.0018
723 ABDOMINAL PAIN LOWER 45 0.0018
724 DYSGEUSIA 132 0.0018
725 BRONCHOSPASM 25 0.0018
726 PAIN IN EXTREMITY 515 0.0017
727 OXYGEN SATURATION DECREASED 98 0.0017
728 DYSPNOEA 985 0.0017
729 HOT FLUSH 131 0.0017
730 TENDERNESS 18 0.0017
731 VISION BLURRED 237 0.0017
732 DYSPNOEA EXERTIONAL 65 0.0017
733 HEPATIC CYTOLYSIS 22 0.0017
734 MUSCULOSKELETAL STIFFNESS 150 0.0017
735 HEAD DISCOMFORT 30 0.0017
736 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 81 0.0017
737 AGRANULOCYTOSIS 31 0.0017
738 EYE PAIN 94 0.0017
739 TOOTHACHE 30 0.0017
740 EAR DISCOMFORT 17 0.0017
741 SKIN DISORDER 55 0.0016
742 PHOTOPHOBIA 31 0.0016
743 VISUAL IMPAIRMENT 204 0.0016
744 BLOOD SODIUM DECREASED 31 0.0016
745 RESTLESSNESS 60 0.0016
746 LUNG DISORDER 80 0.0016
747 GENERALISED TONIC-CLONIC SEIZURE 27 0.0016
748 LIVER FUNCTION TEST INCREASED 35 0.0016
749 BURNING SENSATION 114 0.0016
750 GENERALISED OEDEMA 20 0.0016
751 ACUTE KIDNEY INJURY 247 0.0016
752 RENAL FAILURE ACUTE 68 0.0016
753 IMPAIRED QUALITY OF LIFE 23 0.0016
754 MUSCLE SPASMS 292 0.0016
755 FLUID OVERLOAD 23 0.0016
756 ABASIA 39 0.0016
757 CONJUNCTIVITIS 29 0.0016
758 PRURITUS 600 0.0016
759 LOSS OF CONSCIOUSNESS 200 0.0016
760 PHARYNGEAL OEDEMA 24 0.0016
761 INTERVERTEBRAL DISC PROTRUSION 34 0.0016
762 CELLULITIS 78 0.0015
763 PULMONARY OEDEMA 69 0.0015
764 ABDOMINAL PAIN UPPER 317 0.0015
765 DENTAL CARIES 17 0.0015
766 NERVOUSNESS 80 0.0015
767 INFLUENZA LIKE ILLNESS 126 0.0015
768 MOUTH ULCERATION 32 0.0015
769 HEAD INJURY 48 0.0015
770 NASAL CONGESTION 89 0.0015
771 BRONCHITIS 112 0.0015
772 HYPERGLYCAEMIA 55 0.0015
773 AMNESIA 98 0.0015
774 EYE SWELLING 56 0.0015
775 NAUSEA 1190 0.0015
776 CHOLELITHIASIS 49 0.0015
777 MALAISE 655 0.0015
778 COVID-19 262 0.0015
779 PERIPHERAL SWELLING 228 0.0015
780 ABDOMINAL DISTENSION 154 0.0015
781 DRUG TOXICITY 20 0.0015
782 OSTEONECROSIS 48 0.0015
783 FALL 486 0.0015
784 BLISTER 82 0.0015
785 MYALGIA 248 0.0015
786 MUSCULOSKELETAL DISCOMFORT 25 0.0015
787 HYPOKALAEMIA 67 0.0015
788 TOOTH INFECTION 19 0.0014
789 LIMB INJURY 39 0.0014
790 BONE PAIN 84 0.0014
791 NEPHROLITHIASIS 65 0.0014
792 VOMITING 663 0.0014
793 DEHYDRATION 187 0.0014
794 THERAPY NON-RESPONDER 63 0.0014
795 UVEITIS 19 0.0014
796 PANIC ATTACK 51 0.0014
797 PARANOIA 24 0.0014
798 PULMONARY EMBOLISM 132 0.0014
799 ILLNESS 143 0.0014
800 TUBULOINTERSTITIAL NEPHRITIS 26 0.0014
801 NODULE 18 0.0014
802 LETHARGY 79 0.0014
803 ABORTION SPONTANEOUS 55 0.0014
804 COLITIS 52 0.0014
805 MOOD SWINGS 43 0.0013
806 INTERSTITIAL LUNG DISEASE 65 0.0013
807 HAEMATOCHEZIA 74 0.0013
808 DIZZINESS 661 0.0013
809 NERVOUS SYSTEM DISORDER 41 0.0013
810 DISTURBANCE IN ATTENTION 70 0.0013
811 SOMNOLENCE 261 0.0013
812 BLOOD POTASSIUM INCREASED 21 0.0013
813 SWELLING FACE 84 0.0013
814 EXPOSURE DURING PREGNANCY 80 0.0013
815 DISORIENTATION 51 0.0013
816 DYSMENORRHOEA 17 0.0013
817 SEIZURE 148 0.0013
818 HEPATIC ENZYME INCREASED 87 0.0013
819 SYNCOPE 127 0.0013
820 IMPAIRED WORK ABILITY 27 0.0013
821 WEIGHT DECREASED 352 0.0013
822 MUSCLE TWITCHING 29 0.0013
823 CARDIAC FAILURE CONGESTIVE 101 0.0013
824 CONFUSIONAL STATE 202 0.0012
825 PULMONARY HYPERTENSION 26 0.0012
826 MOOD ALTERED 34 0.0012
827 ABDOMINAL DISCOMFORT 209 0.0012
828 WEIGHT INCREASED 279 0.0012
829 DISCOMFORT 76 0.0012
830 HAEMORRHAGE 130 0.0012
831 PULMONARY ARTERIAL HYPERTENSION 18 0.0012
832 TASTE DISORDER 25 0.0012
833 CHOKING 24 0.0012
834 DEPRESSED MOOD 65 0.0012
835 PAIN 755 0.0012
836 ANKLE FRACTURE 19 0.0012
837 EATING DISORDER 26 0.0012
838 TREATMENT FAILURE 101 0.0012
839 THERAPY PARTIAL RESPONDER 19 0.0012
840 CYANOSIS 19 0.0012
841 ANXIETY 342 0.0012
842 OEDEMA 65 0.0012
843 CHOLESTASIS 23 0.0012
844 HYPONATRAEMIA 67 0.0012
845 STOMATITIS 72 0.0012
846 NEOPLASM MALIGNANT 79 0.0012
847 MUSCULOSKELETAL PAIN 62 0.0012
848 WOUND 33 0.0012
849 GASTROOESOPHAGEAL REFLUX DISEASE 95 0.0012
850 GALLBLADDER DISORDER 21 0.0012
851 COMA 56 0.0012
852 VAGINAL HAEMORRHAGE 51 0.0012
853 SCAR 20 0.0012
854 APATHY 17 0.0012
855 DECREASED APPETITE 268 0.0012
856 FULL BLOOD COUNT DECREASED 23 0.0011
857 DEEP VEIN THROMBOSIS 74 0.0011
858 BLOOD TRIGLYCERIDES INCREASED 20 0.0011
859 EYE DISORDER 37 0.0011
860 ANAPHYLACTIC SHOCK 29 0.0011
861 SWELLING 105 0.0011
862 PERITONITIS 23 0.0011
863 BLOOD PRESSURE ABNORMAL 22 0.0011
864 DERMATITIS 23 0.0011
865 CONSTIPATION 237 0.0011
866 HYPERKALAEMIA 38 0.0011
867 BLOOD PRESSURE FLUCTUATION 26 0.0011
868 OEDEMA PERIPHERAL 132 0.0011
869 BLINDNESS 44 0.0011
870 DEPRESSION 245 0.0011
871 HAEMATEMESIS 27 0.0011
872 HEPATIC CIRRHOSIS 20 0.0011
873 CARDIOVASCULAR DISORDER 27 0.0011
874 ACNE 80 0.0011
875 ARTHRALGIA 436 0.0010
876 PNEUMONIA ASPIRATION 26 0.0010
877 DIARRHOEA 661 0.0010
878 LIP SWELLING 34 0.0010
879 THINKING ABNORMAL 19 0.0010
880 PSYCHOTIC DISORDER 30 0.0010
881 THIRST 18 0.0010
882 SLEEP APNOEA SYNDROME 19 0.0010
883 HYPERSENSITIVITY 184 0.0010
884 FLUID RETENTION 50 0.0010
885 CEREBRAL INFARCTION 24 0.0010
886 ERUCTATION 19 0.0010
887 INTENTIONAL PRODUCT USE ISSUE 86 0.0010
888 HYPOPHAGIA 25 0.0010
889 ANGINA PECTORIS 28 0.0010
890 HAEMORRHOIDS 19 0.0010
891 LIVER DISORDER 43 0.0010
892 HOSPITALISATION 146 0.0009
893 FOOT FRACTURE 18 0.0009
894 HYPOACUSIS 40 0.0009
895 PAIN OF SKIN 25 0.0009
896 LACTIC ACIDOSIS 30 0.0009
897 FREQUENT BOWEL MOVEMENTS 25 0.0009
898 AGEUSIA 23 0.0009
899 DELIRIUM 32 0.0009
900 CARDIAC ARREST 75 0.0009
901 THROMBOSIS 72 0.0009
902 JOINT SWELLING 108 0.0009
903 HEPATIC FUNCTION ABNORMAL 33 0.0009
904 CARDIAC FAILURE 70 0.0009
905 TINNITUS 40 0.0009
906 ATRIAL FIBRILLATION 84 0.0009
907 ALOPECIA 169 0.0009
908 ECZEMA 45 0.0009
909 GASTROINTESTINAL DISORDER 77 0.0009
910 RENAL DISORDER 40 0.0009
911 SKIN ULCER 22 0.0009
912 ARRHYTHMIA 40 0.0008
913 AGITATION 61 0.0008
914 TOXICITY TO VARIOUS AGENTS 140 0.0008
915 MELAENA 18 0.0008
916 CARDIO-RESPIRATORY ARREST 34 0.0008
917 NEUROPATHY PERIPHERAL 77 0.0008
918 MENTAL DISORDER 35 0.0008
919 PANCREATITIS ACUTE 18 0.0008
920 OCULAR HYPERAEMIA 38 0.0008
921 SWOLLEN TONGUE 25 0.0008
922 CONVULSION 45 0.0008
923 DRUG INEFFECTIVE 1032 0.0008
924 GASTRIC DISORDER 26 0.0008
925 PANCREATITIS 40 0.0008
926 HALLUCINATION 56 0.0007
927 GASTROINTESTINAL HAEMORRHAGE 62 0.0007
928 PRESYNCOPE 18 0.0007
929 DEPRESSED LEVEL OF CONSCIOUSNESS 29 0.0007
930 IMPAIRED HEALING 24 0.0007
931 DRY MOUTH 59 0.0007
932 ROAD TRAFFIC ACCIDENT 30 0.0007
933 SLEEP DISORDER 50 0.0007
934 FLATULENCE 40 0.0007
935 CATARACT 42 0.0007
936 OSTEOPOROSIS 29 0.0007
937 DRY SKIN 94 0.0007
938 METABOLIC ACIDOSIS 22 0.0007
939 BLOOD CHOLESTEROL INCREASED 31 0.0007
940 ASTHMA 75 0.0007
941 BLOOD GLUCOSE INCREASED 125 0.0007
942 ANGER 22 0.0006
943 RENAL INJURY 19 0.0006
944 RECTAL HAEMORRHAGE 27 0.0006
945 PRODUCT USE ISSUE 116 0.0006
946 ANAPHYLACTIC REACTION 34 0.0006
947 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 108 0.0006
948 MYELOSUPPRESSION 21 0.0006
949 VISUAL ACUITY REDUCED 19 0.0006
950 DYSKINESIA 23 0.0006
951 IRRITABILITY 34 0.0006
952 DIABETES MELLITUS 43 0.0006
953 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
954 MALIGNANT NEOPLASM PROGRESSION 56 0.0005
955 SKIN EXFOLIATION 46 0.0005
956 THERAPEUTIC RESPONSE UNEXPECTED 24 0.0005
957 THERAPY CESSATION 27 0.0005
958 ARTHRITIS 41 0.0005
959 SKIN BURNING SENSATION 37 0.0005
960 ARTHROPATHY 28 0.0005
961 CEREBROVASCULAR ACCIDENT 82 0.0005
962 DRY EYE 24 0.0005
963 ANGIOEDEMA 21 0.0005
964 DRUG INTOLERANCE 45 0.0005
965 DEATH 401 0.0005
966 BREAST CANCER 43 0.0005
967 CARDIAC DISORDER 42 0.0004
968 SUICIDAL IDEATION 37 0.0004
969 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
970 ADVERSE DRUG REACTION 32 0.0004
971 DRUG INTERACTION 56 0.0004
972 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25 0.0004
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
974 INTENTIONAL PRODUCT MISUSE 29 0.0003
975 TREATMENT NONCOMPLIANCE 18 0.0003
976 FOETAL EXPOSURE DURING PREGNANCY 25 0.0003
977 MYOCARDIAL INFARCTION 53 0.0003
978 CHRONIC KIDNEY DISEASE 23 0.0003
979 MATERNAL EXPOSURE DURING PREGNANCY 26 0.0003
980 INJURY 18 0.0003
981 ADVERSE EVENT 21 0.0002
982 EMOTIONAL DISTRESS 25 0.0002
983 RHEUMATOID ARTHRITIS 22 0.0002
984 INJECTION SITE ERYTHEMA 21 0.0002
985 PSORIASIS 22 0.0002
986 NO ADVERSE EVENT 29 0.0002
987 INCORRECT DOSE ADMINISTERED 19 0.0001
988 INJECTION SITE PAIN 21 0.0001